FDA Approves Implant for Bladder Control

FDA Approves Implant for Bladder Control

Overactive bladder (OAB) syndrome affects more than 37 million people in the U.S. to some degree. Some estimate the cost to the country’s healthcare system in the range of $60 billion every year. StimGuard is a company that has developed a novel treatment for...
What Possibly Could Go Wrong?

What Possibly Could Go Wrong?

The Law of Unintended Consequences lurks behind any new technology, sometimes revealing unforeseen benefits but more often resulting in some negative outcome. Wearable Health Tech devices are not immune to this effect, and given the nature of their missions, the...